13F

Stock

Inhibikase Therapeutics, Inc.

IKT · held by 3 managers

Reported value

$257.1K

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$28.2K

Price effect on 1 books still in the name

Largest holder

$138.6K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC85.6K$138.6K−$28.2KCut−$76.4K
MORGAN STANLEY56K$90.8KHeld
BANK OF AMERICA CORP /DE/17.1K$27.7KHeld

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.